Sandler Laura Leeinsider trades
In SEC Form 4 filings, Sandler Laura Lee is listed as Chief Operating Officer of Oruka Therapeutics, Inc. (ORKA). In the last 90 days, Sandler Laura Lee sold $545.8K of Oruka Therapeutics, Inc. (ORKA) on the open market and bought none. 2 of the 3 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ORKAOruka Therapeutics, Inc. | Chief Operating Officer | 5 | Sep 15 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-01
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ORKAOruka Therapeutics, Inc. | Sep 15 | Sep 15 | S | 906 | $95.71 | Sale −$86,713 | 235,478 | No | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 1 | Sep 1 | M | 5,000 | $7.80 | $39,000 | 241,384 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 1 | Sep 1 | S | 1,000 | $91.05 | Sale −$91,048 | 240,384 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 1 | Sep 1 | S | 4,000 | $92.01 | Sale −$368,054 | 236,384 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 1 | Sep 1 | M · derivative | 5,000 | $7.80 | $39,000 | 74,996 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.